Home›Companies›Biotech & Pharma›ThirdLaw Molecular

ThirdLaw Molecular, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 8, 2025·Suggest an edit

About ThirdLaw Molecular

ThirdLaw Molecular is a private company based in Blue Bell, Pennsylvania, incorporated in 2024 in Delaware. It has reported $5,500,000 raised in one offering on Form D since October 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 2, 2025Oct 8, 2025$5,500,000fully sold4$1.3MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ThirdLaw Molecular's Form D filed Oct 8, 2025.

CS
Christian Schafmeister
President and director
DS
David Scheer
Director
BH
Brian Halak
Director
EH
Eric Heil
Executive officer and director

Sources

  1. SECThirdLaw Molecular, Inc. filing history